Summary of Significant Accounting Policies (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Accounting Policies [Abstract]

Summary of Changes in Allowance for Credit Losses

The following table presents changes in the allowance for credit losses for the year ended December 31, 2025:


Balance at December 31, 2025		$	41
Change in provision for credit losses			(15	)
Balance at March 31, 2026		$	26

The following table presents changes in the allowance for credit losses for the year ended December 31, 2025:


Balance - December 31, 2024		$	24,210
Change in provision for credit losses			17,131
Balance - December 31, 2025		$	41,341

Schedule of Basic and Diluted Net Loss Per Share

The calculation of basic and diluted net loss per share attributable to common stock was as follows:

		For the Three Months Ended March 31,
		2026				2025
Numerator:
Net loss attributable to common shareholders—basic and diluted		$	(8,417	)		$	(3,644	)

Denominator:
Weighted average shares—basic and diluted (in thousands)			720				120
Net loss per share attributable to common shareholders—basic and diluted		$	(11.69	)		$	(30.37	)

The calculation of basic and diluted net loss per share attributable to common stock was as follows:

		For the Year Ended December 31,
		2025				2024
Numerator:
Net loss attributable to common shareholders—basic and diluted		$	(22,492,075	)		$	(31,095,029	)

Denominator:
Weighted average shares—basic and diluted			189,150				22,291
Net loss per share attributable to common shareholders—basic and diluted		$	(118.91	)		$	(1,394.94	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss that could potentially be dilutive in future periods are as follows:

		As of March 31,
		2026				2025
Options			628				128
RSUs			26,708				13,039
Public warrant shares			1,150				1,150
GEM warrant shares			83				83
Common warrant shares			100,716				22,638
Placement agent warrant shares			14,912				525
Pre-funded warrants			—				—
Total			144,197				37,563

Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss that could potentially be dilutive in future periods are as follows:


		As of December 31,
		2025				2024
Options			627				129
RSUs			20,695				1,704
Public warrant shares			1,150				1,150
GEM warrant shares			83				83
Common warrant shares			36,800				22,639
Placement agent warrant shares			3,591				525
Pre-funded warrants			—				—
Total			62,952				26,230
Antidilutive Securities			62,952				26,230